209 related articles for article (PubMed ID: 22215816)
1. Management of difficult infantile haemangiomas.
Maguiness SM; Frieden IJ
Arch Dis Child; 2012 Mar; 97(3):266-71. PubMed ID: 22215816
[TBL] [Abstract][Full Text] [Related]
2. Haemangioma: clinical course, complications and management.
Luu M; Frieden IJ
Br J Dermatol; 2013 Jul; 169(1):20-30. PubMed ID: 23701395
[TBL] [Abstract][Full Text] [Related]
3. Infantile haemangiomas: a challenge in paediatric dermatology.
Schwartz RA; Sidor MI; Musumeci ML; Lin RL; Micali G
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):631-8. PubMed ID: 20565561
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for infantile haemangiomas: a review.
Starkey E; Shahidullah H
Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
[TBL] [Abstract][Full Text] [Related]
5. Infantile haemangioma.
Léauté-Labrèze C; Harper JI; Hoeger PH
Lancet; 2017 Jul; 390(10089):85-94. PubMed ID: 28089471
[TBL] [Abstract][Full Text] [Related]
6. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
Michel JL; Patural H
Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
[TBL] [Abstract][Full Text] [Related]
7. Unusual presentation of GLUT-1 positive infantile haemangioma.
Koh C; Sugo E; Wargon O
Australas J Dermatol; 2009 May; 50(2):136-40. PubMed ID: 19397570
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
9. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
10. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
11. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
12. Infantile haemangioma: part II. Risks, complications and treatment.
Léauté-Labrèze C; Prey S; Ezzedine K
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1254-60. PubMed ID: 21569113
[TBL] [Abstract][Full Text] [Related]
13. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
[TBL] [Abstract][Full Text] [Related]
14. Propranolol for recalcitrant ulcerated hemangioma of infancy.
Hong E; Fischer G
Pediatr Dermatol; 2012; 29(1):64-7. PubMed ID: 21854419
[TBL] [Abstract][Full Text] [Related]
15. Current treatment practices in the management of cutaneous haemangioma.
Chan YC
Expert Opin Pharmacother; 2004 Sep; 5(9):1937-42. PubMed ID: 15330731
[TBL] [Abstract][Full Text] [Related]
16. Abortive segmental perineal hemangioma.
Tlougan BE; Gonzalez ME; Orlow SJ
Dermatol Online J; 2011 Oct; 17(10):8. PubMed ID: 22031634
[TBL] [Abstract][Full Text] [Related]
17. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
18. Current management of infantile hemangiomas.
Maguiness SM; Frieden IJ
Semin Cutan Med Surg; 2010 Jun; 29(2):106-14. PubMed ID: 20579599
[TBL] [Abstract][Full Text] [Related]
19. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
